Lv2
176 积分 2022-06-06 加入
Lactylation‐Driven IGF2BP3‐Mediated Serine Metabolism Reprogramming and RNA m6A—Modification Promotes Lenvatinib Resistance in HCC
2小时前
待确认
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
25天前
已完结
Disease Etiology and Outcomes After Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma: Post-Hoc Analysis of IMbrave150
25天前
已完结
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
25天前
已完结
Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial
25天前
已完结
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
25天前
已完结
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
1个月前
已完结
TRPML1 triggers ferroptosis defense and is a potential therapeutic target in AKT-hyperactivated cancer
1个月前
已完结
STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma
1个月前
已完结
CRISPR activation and interference screens decode stimulation responses in primary human T cells
1个月前
已完结
皖公网安备34019202002308
